Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs.
The present study has evaluated the protection conferred by a single subcutaneous dose of a modified vaccinia virus Ankara (MVA) vectored vaccine encoding the Rift Valley Fever virus (RVFV) glycoproteins Gn and Gc in lambs. Three groups of six to seven lambs were immunized as follows: one group rece...
Κύριοι συγγραφείς: | Busquets, N, Lorenzo, G, López-Gil, E, Rivas, R, Solanes, D, Galindo-Cardiel, I, Abad, F, Rodríguez, F, Bensaid, A, Warimwe, G, Gilbert, S, Domingo, M, Brun, A |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
Elsevier
2014
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs
ανά: Busquets, N, κ.ά.
Έκδοση: (2014) -
Evaluation of the protective potential of a recombinant modified vaccinia virus Ankara (MVA) encoding rift valley fever virus (RVFV) glycoproteins in lambs
ανά: Busquets, N, κ.ά.
Έκδοση: (2011) -
Rift Valley fever: biology and epidemiology
ανά: Wright, D, κ.ά.
Έκδοση: (2019) -
Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice.
ανά: Warimwe, G, κ.ά.
Έκδοση: (2013) -
MVA Vectored Vaccines Encoding Rift Valley Fever Virus Glycoproteins Protect Mice against Lethal Challenge in the Absence of Neutralizing Antibody Responses
ανά: Elena López-Gil, κ.ά.
Έκδοση: (2020-02-01)